AptarGroup Inc (ATR) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets.

Total Cash From Operating Activities Chart for AptarGroup Inc

AptarGroup Inc (ATR) operating cash flow for FY2025 was USD 570.0M, a -11.4% change from FY2024. AptarGroup Inc's operating cash flow grew from USD 45.2M in 1992 to USD 570.0M in 2025 (1161.1% over 33 years). Operating cash flow compound annual growth rate: 5-year CAGR of -0.0%, 10-year CAGR of 5.8%, 20-year CAGR of 5.5%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$7.65B
Implied Share Price
$120.25
Enterprise Value
$9.15B
Revenue (TTM)
$3.93B
EBITDA
$798.40M
Profit Margin
9.22%
Trailing P/E
21.78
Forward P/E
19.76
Price/Book (MRQ)
3.02
Price/Sales (TTM)
1.94
EV/EBITDA
11.08
EV/Revenue
2.33
Dividend Yield
1.57%
Book Value
$41.33
Free Cash Flow (FY2025)
$299.58M
Free Cash Flow Yield
3.92%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.